BeOne Medicines (ONC) EBT Margin (2015 - 2026)
BeOne Medicines (ONC) posted quarterly EBT Margin of 17.13% for Q1 2026, up 1526.0% year-over-year from 1.05% in Q1 2025, and up 71.94% quarter-over-quarter from 9.96% in Q4 2025.
BeOne Medicines (ONC) EBT Margin (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported EBT Margin for 12 consecutive years, with 17.13% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin rose 1526.0% year-over-year to 17.13%; the TTM figure through Mar 2026 stood at 11.42% (up 1785.0% YoY), while the FY2025 annual figure was 7.8%, up 2179.0% from the prior year.
- EBT Margin rose to 17.13% in Q1 2026 per ONC's latest filing, from 9.96% in the prior quarter.
- Across five years, EBT Margin topped out at 29.35% in Q3 2023 and bottomed at 163.24% in Q2 2022.
- Historically, EBT Margin has averaged 43.14% across 5 years, with a median of 11.4% in 2024.
- Annual changes were most pronounced in 2022 — EBT Margin slumped 14759 bps — and 2023, when it surged 17156 bps.
- BeOne Medicines' EBT Margin stood at 113.38% in 2022, then jumped by 51 bps to 55.29% in 2023, then jumped by 86 bps to 7.57% in 2024, then surged by 232 bps to 9.96% in 2025, then surged by 72 bps to 17.13% in 2026.
- Business Quant data shows ONC's EBT Margin at 17.13% in Q1 2026, 9.96% in Q4 2025, and 10.42% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -20,427.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.33% |
| Mar 31, 2026 | 17.13% |
| Dec 31, 2025 | 9.96% |
| Sep 30, 2025 | 10.42% |
| Jun 30, 2025 | 7.57% |
| Mar 31, 2025 | 1.87% |
| Dec 31, 2024 | -7.57% |
| Sep 30, 2024 | -9.81% |
| Jun 30, 2024 | -11.40% |
| Mar 31, 2024 | -32.39% |
| Dec 31, 2023 | -55.29% |
| Sep 30, 2023 | 29.35% |
| Jun 30, 2023 | -61.73% |
| Mar 31, 2023 | -75.24% |
| Dec 31, 2022 | -113.38% |
| Sep 30, 2022 | -142.21% |
| Jun 30, 2022 | -163.24% |
| Mar 31, 2022 | -137.38% |
| Dec 31, 2021 | -283.22% |
| Sep 30, 2021 | -209.78% |